| Name | (4S)-4-amino-5-[[(2S)-1-[[(2S,3S)-1-[(2S)-2-[[(1S)-1-carboxyethyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid |
|---|---|
| Synonyms |
(4S)-4-amino-5-[[(2S)-1-[[(2S,3S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
Glutamyl-histidyl-isoleucyl-prolyl-alanine Glu-his-ile-pro-ala |
| Description | Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen-Binding Peptide binds fibrinogen and inhibits both the adhesion of platelets to fibrinogen and platelet aggregation, and also inhibits the adhesion of platelets to vitronectin[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.343 g/cm3 |
|---|---|
| Boiling Point | 1067.8ºC at 760 mmHg |
| Molecular Formula | C25H39N7O8 |
| Molecular Weight | 565.62 |
| Flash Point | 599.6ºC |
| Exact Mass | 565.28600 |
| PSA | 236.91000 |
| LogP | 0.55120 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 1.577 |